NDC 64896-682

ZOMIG

Zolmitriptan

ZOMIG is a Nasal Spray, Metered in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals. The primary component is Zolmitriptan.

Product ID64896-682_b023615a-7793-41a1-abbc-b89bd120b0d3
NDC64896-682
Product TypeHuman Prescription Drug
Proprietary NameZOMIG
Generic NameZolmitriptan
Dosage FormSpray, Metered
Route of AdministrationNASAL
Marketing Start Date2013-12-06
Marketing CategoryNDA / NDA
Application NumberNDA021450
Labeler NameAmneal Pharmaceuticals
Substance NameZOLMITRIPTAN
Active Ingredient Strength3 mg/1
Pharm ClassesSerotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 64896-682-30

1 BOTTLE, SPRAY in 1 CARTON (64896-682-30) > 1 SPRAY, METERED in 1 BOTTLE, SPRAY
Marketing Start Date2013-12-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64896-682-51 [64896068251]

ZOMIG SPRAY, METERED
Marketing CategoryNDA
Application NumberNDA021450
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-12-06

NDC 64896-682-30 [64896068230]

ZOMIG SPRAY, METERED
Marketing CategoryNDA
Application NumberNDA021450
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-12-06

Drug Details

Active Ingredients

IngredientStrength
ZOLMITRIPTAN2.5 mg/1

OpenFDA Data

SPL SET ID:84b51cb9-83f3-4a49-7fa3-1adc0f963658
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 402169
  • 1483677
  • 402000
  • 1483679
  • Pharmacological Class

    • Serotonin 1b Receptor Agonists [MoA]
    • Serotonin 1d Receptor Agonists [MoA]
    • Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

    Medicade Reported Pricing

    64896068251 ZOMIG 2.5 MG NASAL SPRAY

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "ZOMIG" or generic name "Zolmitriptan"

    NDCBrand NameGeneric Name
    21695-955ZOMIGZolmitriptan
    68258-7103ZOMIGZOMIG
    64896-682ZOMIGZOMIG
    64896-672ZOMIGZOMIG
    64896-681ZOMIGZOMIG
    64896-671ZOMIGZOMIG
    0115-0671ZolmitriptanZolmitriptan
    0115-0672ZolmitriptanZolmitriptan
    16571-803ZolmitriptanZolmitriptan
    16571-804ZolmitriptanZolmitriptan
    27241-021ZolmitriptanZolmitriptan
    27241-022ZolmitriptanZolmitriptan
    31722-458ZOLMITRIPTANZOLMITRIPTAN
    31722-459ZOLMITRIPTANZOLMITRIPTAN
    33342-112ZolmitriptanZolmitriptan
    33342-113ZolmitriptanZolmitriptan
    33342-139ZolmitriptanZolmitriptan
    33342-140ZolmitriptanZolmitriptan
    45802-711zolmitriptanzolmitriptan
    46708-181ZolmitriptanZolmitriptan
    46708-182ZolmitriptanZolmitriptan
    46708-462ZolmitriptanZolmitriptan
    46708-463ZolmitriptanZolmitriptan
    50742-625ZolmitriptanZolmitriptan
    50742-626ZolmitriptanZolmitriptan
    55700-943ZolmitriptanZolmitriptan
    55700-944ZolmitriptanZolmitriptan
    55801-322ZolmitriptanZolmitriptan
    55801-323ZolmitriptanZolmitriptan
    59746-432ZolmitriptanZolmitriptan
    59746-433ZolmitriptanZolmitriptan
    59746-461Zolmitriptan ODZolmitriptan
    59746-462Zolmitriptan ODZolmitriptan
    0115-0691Zolmitriptan Orally DisintegratingZolmitriptan
    0115-0692Zolmitriptan Orally DisintegratingZolmitriptan

    Trademark Results [ZOMIG]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZOMIG
    ZOMIG
    74719034 2175295 Live/Registered
    Wellcome Foundation Limited, The
    1995-08-22

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.